IRF1	chr5	132,481,608	132,490,773	minus	NA	NA	NA	NA	No	Yes	No	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the IRF1 gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
JARID2	chr6	15,245,974	15,522,042	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the JARID2 gene on chr6 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
KANK1	chr9	504,694	746,103	plus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the KANK1 gene on chr9 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
KIF5B	chr10	32,009,014	32,056,425	minus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the KIF5B gene on chr10 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
KMT2C	chr7	152,134,924	152,436,005	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the KMT2C gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
KMT2E	chr7	105,014,178	105,114,085	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the KMT2E gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
L3MBTL1	chr20	43,507,679	43,541,895	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the L3MBTL1 gene on chr20 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
LAMB1	chr7	107,923,800	108,003,359	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the LAMB1 gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
LINC00982	chr1	3,059,616	3,067,725	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the LINC00982 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
LLGL2	chr17	75,525,701	75,575,209	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the LLGL2 gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
LUC7L2	chr7	139,340,358	139,423,457	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the LUC7L2 gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MAL	chr2	95,025,654	95,053,996	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MAL gene on chr2 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MAP2K1	chr15	66,386,816	66,492,312	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MAP2K1 gene on chr15 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MDS2	chr1	23,627,333	23,640,568	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MDS2 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MGA	chr15	41,621,223	41,769,943	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MGA gene on chr15 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MKL1	chr22	40,410,280	40,636,719	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MKL1 gene on chr22 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MLLT11	chr1	151,057,757	151,068,497	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MLLT11 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MRTFA	chr22	40,410,281	40,636,719	minus	Acute myeloid leukaemia with defining genetic abnormalities; Acute myeloid leukaemia with RBM15::MRTFA fusion, (WHO, PMID: 35732831).	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	1A	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the MRTFA gene on chr22 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MSI2	chr17	57,255,850	57,684,689	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MSI2 gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MYB	chr6	135,181,307	135,219,172	plus	NA	NA	NA	NA	No	Yes	Yes	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the MYB gene on chr6 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MYBL2	chr20	43,667,018	43,716,496	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MYBL2 gene on chr20 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MYD88	chr3	38,138,660	38,143,022	plus	NA	NA	NA	NA	No	Yes	No	Duplication/CN gain	GOF	AML	2	NA	Optical Genome Mapping detected a [Duplication/CN gain] mutation involving the MYD88 gene on chr3 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MYO18A	chr17	29,073,509	29,180,412	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MYO18A gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MYSM1	chr1	58,654,744	58,700,062	minus	NA	NA	NA	NA	Expanded	No	No	Deletion/CN loss	LOF	AML	3A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MYSM1 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
NFE2	chr12	54,292,110	54,295,758	minus	NA	NA	NA	NA	No	Yes	No	Duplication/CN gain	GOF	AML	2	NA	Optical Genome Mapping detected a [Duplication/CN gain] mutation involving the NFE2 gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
NIN	chr14	50,719,762	50,831,162	minus	NA	NA	NA	NA	No	Yes	Yes	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the NIN gene on chr14 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
P2RY8_chrX	chrX	1,462,580	1,537,185	minus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the P2RY8_chrX gene on chrX with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
P2RY8_chrY	chrY	1,462,580	1,537,185	minus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the P2RY8_chrY gene on chrY with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
PCM1	chr8	17,922,987	18,029,948	plus	NA	NA	NA	NA	No	Yes	Yes	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the PCM1 gene on chr8 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
PDE4DIP	chr1	148,844,427	149,033,016	plus	NA	NA	NA	NA	No	Yes	Yes	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the PDE4DIP gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
PER1	chr17	8,140,469	8,156,360	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PER1 gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
PPM1D	chr17	60,600,192	60,666,280	plus	NA	NA	NA	NA	Expanded	Yes	Yes	Deletion/CN loss	LOF	AML	3A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PPM1D gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
PRKG1	chr10	50,991,150	52,298,350	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PRKG1 gene on chr10 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
PRKG2	chr4	81,087,374	81,215,222	minus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the PRKG2 gene on chr4 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
PRPF40B	chr12	49,623,414	49,644,669	plus	NA	NA	NA	NA	Core	No	Yes	Deletion/CN loss	LOF	AML	3A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PRPF40B gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
PRPF8	chr17	1,650,628	1,684,867	minus	NA	NA	NA	NA	No	Yes	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PRPF8 gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
PTPRT	chr20	42,072,751	43,189,970	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PTPRT gene on chr20 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
RABEP1	chr17	5,282,283	5,386,340	plus	NA	NA	NA	NA	No	Yes	Yes	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the RABEP1 gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
RBBP6	chr16	24,539,586	24,572,863	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the RBBP6 gene on chr16 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
RBM22	chr5	150,690,789	150,701,107	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the RBM22 gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
RCOR1	chr14	102,592,658	102,730,576	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the RCOR1 gene on chr14 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
RELN	chr7	103,471,783	103,989,516	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the RELN gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
RIT1	chr1	155,897,808	155,911,349	minus	NA	NA	NA	NA	Expanded	No	No	Deletion/CN loss	LOF	AML	3A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the RIT1 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
RPL11	chr1	23,691,806	23,696,835	plus	NA	NA	NA	NA	Expanded	No	No	Deletion/CN loss	LOF	AML	3A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the RPL11 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
RPL22	chr1	6,181,268	6,200,842	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the RPL22 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
RPS14	chr5	150,443,189	150,449,756	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the RPS14 gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
SALL3	chr18	78,980,274	78,999,974	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SALL3 gene on chr18 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
SAMD9	chr7	93,099,513	93,118,023	minus	NA	Hematologic neoplasms with germline predisposition associated with a constitutional disorder affecting multiple organ systems; Myeloid neoplasms with germline SAMD9 mutation, (ICC, PMID: 35767897).	NA	NA	Expanded	No	No	Deletion/CN loss	LOF	AML	1A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SAMD9 gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
SAMD9L	chr7	93,130,056	93,148,385	minus	NA	Hematologic neoplasms with germline predisposition associated with a constitutional disorder affecting multiple organ systems; Myeloid neoplasms with germline SAMD9L mutation, (ICC, PMID: 35767897).	NA	NA	No	No	No	Deletion/CN loss	LOF	AML	1A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SAMD9L gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
SBDS	chr7	66,987,680	66,995,586	minus	NA	NA	NA	NA	Expanded	No	Yes	Deletion/CN loss	LOF	AML	3A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SBDS gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
SETBP1	chr18	44,680,887	45,068,510	plus	NA	NA	NA	NA	Expanded	Yes	Yes	Duplication/CN gain	GOF	AML	3A	NA	Optical Genome Mapping detected a [Duplication/CN gain] mutation involving the SETBP1 gene on chr18 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
SF1	chr11	64,764,604	64,778,844	minus	NA	NA	NA	NA	Core	No	Yes	Deletion/CN loss	LOF	AML	3A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SF1 gene on chr11 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
SF3A1	chr22	30,331,988	30,356,894	minus	NA	NA	NA	NA	Core	No	Yes	Deletion/CN loss	LOF	AML	3A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SF3A1 gene on chr22 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
SF3B1	chr2	197,388,515	197,435,079	minus	Classification and defining features of myelodysplastic neoplasms (MDS); MDS with low blasts and SF3B1 mutationa (MDS-SF3B1). Defining somatic mutations in acute myeloid leukaemia, myelodysplasia-related; Cytogenetic and molecular abnormalities defining acute myeloid leukaemia, myelodysplasia-related., (WHO, PMID: 35732831).	Classification of AML with percentage of blasts required for diagnosis; Defined by mutations in ASXL1, BCOR, EZH2, RUNX1, SF3B1, SRSF2, STAG2, U2AF1, or ZRSR2. Premalignant clonal cytopenias and myelodysplastic syndromes; Myelodysplastic syndrome with mutated SF3B1, (ICC, PMID: 35767897).	NA	NA	Core	Yes	Yes	Deletion/CN loss	LOF	AML	1A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SF3B1 gene on chr2 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
SGK2	chr20	43,558,967	43,585,677	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SGK2 gene on chr20 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
SOCS2	chr12	93,569,813	93,576,745	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SOCS2 gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
SOCS3	chr17	78,356,777	78,360,079	minus	NA	NA	NA	NA	Core	No	Yes	Deletion/CN loss	LOF	AML	3A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SOCS3 gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
SPARC	chr5	151,661,095	151,687,165	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SPARC gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
SPECC1	chr17	20,009,335	20,319,026	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SPECC1 gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
SPTBN1	chr2	54,456,326	54,671,446	plus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the SPTBN1 gene on chr2 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
SRP72	chr4	56,467,617	56,503,681	plus	NA	NA	NA	NA	Expanded	No	No	Deletion/CN loss	LOF	AML	3A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SRP72 gene on chr4 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
SSBP2	chr5	81,413,020	81,751,253	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SSBP2 gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
STAT3	chr17	42,313,323	42,388,442	minus	NA	NA	NA	NA	No	Yes	No	Duplication/CN gain	GOF	AML	2	NA	Optical Genome Mapping detected a [Duplication/CN gain] mutation involving the STAT3 gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
STAT5a	chr17	42,287,546	42,311,943	plus	NA	NA	NA	NA	No	Yes	No	Duplication/CN gain	GOF	AML	2	NA	Optical Genome Mapping detected a [Duplication/CN gain] mutation involving the STAT5a gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
STAT5b	chr17	42,199,176	42,276,391	minus	NA	NA	NA	NA	No	Yes	No	Duplication/CN gain	GOF	AML	2	NA	Optical Genome Mapping detected a [Duplication/CN gain] mutation involving the STAT5b gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
trisomy 8	chr8	1	145,138,636	NA	NA	NA	NA	NA	No	No	No	trisomy 8	Structural aberration	AML	1A	NA	Optical Genome Mapping detected a trisomy 8 with a fractional copy number of [].	In the context of AML, this variant has unknown prognosis.
STIM1	chr11	3,855,664	4,093,208	plus	NA	NA	NA	NA	Expanded	No	No	Deletion/CN loss	LOF	AML	3A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the STIM1 gene on chr11 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
STRN	chr2	36,837,697	36,966,536	minus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the STRN gene on chr2 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
SUZ12	chr17	31,937,009	32,001,045	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SUZ12 gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
